Search details
1.
Substantial health and economic burden of COVID-19 during the year after acute illness among US adults at high risk of severe COVID-19.
BMC Med
; 22(1): 46, 2024 02 01.
Article
in English
| MEDLINE | ID: mdl-38303065
2.
Assessment of retrospective collection of EQ-5D-5L in a US COVID-19 population.
Health Qual Life Outcomes
; 21(1): 103, 2023 Sep 08.
Article
in English
| MEDLINE | ID: mdl-37679771
3.
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation.
J Thromb Thrombolysis
; 56(4): 626-634, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37530954
4.
Economic burden of COVID-19 for employers and employees in the United States.
J Med Econ
; 27(1): 267-278, 2024.
Article
in English
| MEDLINE | ID: mdl-38294896
5.
Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study.
Vaccines (Basel)
; 12(2)2024 Feb 11.
Article
in English
| MEDLINE | ID: mdl-38400166
6.
Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States.
J Med Econ
; 26(1): 509-524, 2023.
Article
in English
| MEDLINE | ID: mdl-36942976
7.
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity.
Adv Ther
; 40(3): 887-902, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36527598
8.
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data.
Expert Rev Vaccines
; 22(1): 54-65, 2023.
Article
in English
| MEDLINE | ID: mdl-36527724
9.
Public health impact of UK COVID-19 booster vaccination programs during Omicron predominance.
Expert Rev Vaccines
; 22(1): 90-103, 2023.
Article
in English
| MEDLINE | ID: mdl-36519401
10.
The impact of COVID-19 vaccination in the US: Averted burden of SARS-COV-2-related cases, hospitalizations and deaths.
PLoS One
; 18(4): e0275699, 2023.
Article
in English
| MEDLINE | ID: mdl-37098043
11.
Impact of COVID-19 and effects of booster vaccination with BNT162b2 on six-month long COVID symptoms, quality of life, work productivity and activity impairment during Omicron.
J Patient Rep Outcomes
; 7(1): 77, 2023 07 24.
Article
in English
| MEDLINE | ID: mdl-37486567
12.
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as a Case Study.
Vaccines (Basel)
; 11(2)2023 Jan 20.
Article
in English
| MEDLINE | ID: mdl-36851112
13.
The impact of vaccination and outpatient treatment on the economic burden of Covid-19 in the United States omicron era: a systematic literature review.
J Med Econ
; 26(1): 1519-1531, 2023.
Article
in English
| MEDLINE | ID: mdl-37964554
14.
Clinical outcomes of COVID-19 and influenza in hospitalized children <5 years in the US.
Front Pediatr
; 11: 1261046, 2023.
Article
in English
| MEDLINE | ID: mdl-37753191
15.
Impact of COVID-19 Infection on Health-Related Quality of Life, Work Productivity and Activity Impairment by Symptom-Based Long COVID Status and Age in the US.
Healthcare (Basel)
; 11(20)2023 Oct 21.
Article
in English
| MEDLINE | ID: mdl-37893865
16.
Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy.
Vaccines (Basel)
; 11(11)2023 Oct 31.
Article
in English
| MEDLINE | ID: mdl-38006001
17.
Estimated Effectiveness of Coadministration of the BNT162b2 BA.4/5 COVID-19 Vaccine With Influenza Vaccine.
JAMA Netw Open
; 6(11): e2342151, 2023 Nov 01.
Article
in English
| MEDLINE | ID: mdl-37938846
18.
Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.
J Med Econ
; 25(1): 1039-1050, 2022.
Article
in English
| MEDLINE | ID: mdl-36097853
19.
Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA.
Am J Cardiovasc Drugs
; 22(3): 333-343, 2022 May.
Article
in English
| MEDLINE | ID: mdl-34671944
20.
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies.
Expert Rev Vaccines
; 21(4): 435-451, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35112973